PHGE
Income statement / Annual
Last year (2024), BiomX Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, BiomX Inc.'s net income was -$17.73 M.
See BiomX Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$1.80 M
|
$871.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$210.00 K
|
$95.00 K
|
| Gross Profit |
-$1.80 M
|
-$871.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$210.00 K
|
-$95.00 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$24.66 M
|
$19.04 M
|
$16.24 M
|
$22.68 M
|
$21.61 M
|
$13.96 M
|
$9.57 M
|
$4.74 M
|
| General & Administrative Expenses |
$11.78 M
|
$0.00
|
$9.46 M
|
$11.27 M
|
$9.06 M
|
$8.24 M
|
$3.36 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$926.00 K
|
$479.00 K
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$11.78 M
|
$7.78 M
|
$9.46 M
|
$11.27 M
|
$9.99 M
|
$8.72 M
|
$3.36 M
|
$2.54 M
|
| Other Expenses |
$785.00 K
|
$0.00
|
$1.52 M
|
$1.52 M
|
-$1.34 M
|
-$466.00 K
|
$0.00
|
$0.00
|
| Operating Expenses |
$37.22 M
|
$26.81 M
|
$27.22 M
|
$35.46 M
|
$30.26 M
|
$22.21 M
|
$12.93 M
|
$7.28 M
|
| Cost And Expenses |
$39.03 M
|
$27.69 M
|
$27.22 M
|
$35.46 M
|
$30.26 M
|
$22.21 M
|
$13.14 M
|
$7.37 M
|
| Interest Income |
$1.05 M
|
$1.12 M
|
$902.00 K
|
$2.00 K
|
$641.00 K
|
$921.00 K
|
$0.00
|
-$21.00 K
|
| Interest Expense |
$2.79 M
|
$2.40 M
|
$2.07 M
|
$699.00 K
|
$7.00 K
|
$64.00 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.80 M
|
$871.00 K
|
$2.52 M
|
$2.57 M
|
$662.00 K
|
$318.00 K
|
$210.00 K
|
$95.00 K
|
| EBITDA |
-$13.13 M |
-$22.82 M |
-$23.66 M |
-$32.90 M |
-$29.60 M |
-$21.89 M |
-$12.51 M |
-$6.34 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$21.31 M
|
$1.54 M
|
-$1.03 M
|
-$697.00 K
|
$172.00 K
|
$1.64 M
|
$421.00 K
|
$939.00 K
|
| Income Before Tax |
-$17.71 M
|
-$26.15 M
|
-$28.25 M
|
-$36.16 M
|
-$30.09 M
|
-$20.56 M
|
-$12.72 M
|
-$6.43 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$13.00 K
|
$23.00 K
|
$65.00 K
|
$67.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$17.73 M
|
-$26.17 M
|
-$28.32 M
|
-$36.23 M
|
-$30.09 M
|
-$20.56 M
|
-$12.72 M
|
-$6.43 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.47 |
-5.1 |
-9.49 |
-13.93 |
-1.3 |
-0.84 |
-6.46 |
-3.27 |
| EPS Diluted |
-1.47 |
-5.1 |
-9.49 |
-13.93 |
-1.3 |
-0.84 |
-6.46 |
-3.27 |
| Weighted Average Shares Out |
$69.81 M
|
$51.33 M
|
$29.85 M
|
$26.01 M
|
$23.06 M
|
$22.63 M
|
$20.02 M
|
$19.68 M
|
| Weighted Average Shares Out Diluted |
$13.14 B
|
$51.33 M
|
$29.85 M
|
$26.01 M
|
$23.06 M
|
$22.63 M
|
$20.02 M
|
$19.68 M
|
| Link |
|
|
|
|
|
|
|
|
